New Pd(II) complexes containing hydrazinyl oxazolyl coumarin derivatives: synthesis, spectral characterization and anti-cancer studies

Author:

Parveen Sheikdawood1,Deebakkrishnan Ganesan2,Kosiha Arumugam3,Kalaiarasi Giriraj24

Affiliation:

1. BioInspired Material Research Laboratory, Dr. Mahalingam College of Engineering and Technology, Pollachi , Coimbatore 642 003 , India

2. Department of Chemistry , Karpagam Academy of Higher Education (Deemed to be University) , Coimbatore 641 021 , India

3. School of Basic Sciences , Vels Institute of Science, Technology & Advanced Studies (Deemed to be University) , Chennai 600 117 , India

4. Centre for Material Chemistry, Karpagam Academy of Higher Education (Deemed to be University) , Coimbatore 641 021 , India

Abstract

Abstract New palladium(II) complexes containing coumarin derivatives such as (E)-3(2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazinyl)oxazol-4-yl)-2H-chromen-2-one (HL 1 ), (E)-7-hydroxy-3(2-(2-(1-(2-oxo-2H-chromen-3-yl)ethylidene)hydrazinyl)oxazol-4-yl)-2H-chromen-2-one (HL 2 ) were successfully designed and synthesized from the reaction of K2[PdCl4] with ligands HL 1&2 with in Methanol medium. The ligands and complexes were characterized by various analytical and spectral techniques such as FT-IR, UV–Vis, 1H NMR and 13C NMR spectral techniques. From the spectral data we confirmed that the ligands neutrally coordinated with Pd(II) ion via their lactone oxygen, azomethine nitrogen and oxazolyl ring nitrogen atoms. The electrolytic nature of the complexes was confirmed by using conductivity experiments. Further anticancer activity of the compounds has examined with HeLa (human cervical cancer) cells along with the cisplatin as positive control and the obtained results revealed that the complexes possess significant anticancer activity and non-toxic towards HUVEC (human umbilical vein endothelial) cells.

Publisher

Walter de Gruyter GmbH

Subject

Physical and Theoretical Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3